PMN
Price:
$10.54
Market Cap:
$13.78M
ProMIS Neurosciences, Inc. is a Canadian biotechnology firm dedicated to creating targeted therapeutic solutions for debilitating neurodegenerative conditions such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company leverages a unique computational discovery platform, utilizing its ProMIS and Collective Coordinates algorithms, to identify novel, disease-specific targets – known as epitopes – located on the surface of misfolded proteins. Its pipeline features several promising drug candidates, including PMN310, a monoclonal antibody designed to address toxic oligomers implicated in Alzheimer's disease. Another candidate, PMN267, tar...[Read more]
Industry
Biotechnology
IPO Date
2007-01-10
Stock Exchange
NASDAQ
Ticker
PMN
According to ProMIS Neurosciences, Inc.’s latest financial reports and current stock price. The company's current ROE is -237.99%. This represents a change of -128.39% compared to the average of 838.23% of the last 4 quarters.
The mean historical ROE of ProMIS Neurosciences, Inc. over the last ten years is -243.16%. The current -237.99% ROE has changed -2.13% with respect to the historical average. Over the past ten years (40 quarters), PMN's ROE was at its highest in in the June 2025 quarter at 2.64%. The ROE was at its lowest in in the March 2024 quarter at -4714.83%.
Average
-243.16%
Median
-239.79%
Minimum
-3702.09%
Maximum
3.16%
Discovering the peaks and valleys of ProMIS Neurosciences, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 18.62%
Maximum Annual ROE = 3.16%
Minimum Annual Increase = -691.38%
Minimum Annual ROE = -3702.09%
| Year | ROE | Change |
|---|---|---|
| 2025 | 3.16% | 18.62% |
| 2024 | 16.85% | -103.61% |
| 2023 | -466.42% | -147.12% |
| 2022 | 989.81% | -691.38% |
| 2021 | -167.37% | -130.03% |
| 2020 | 557.37% | -130.00% |
| 2019 | -1857.79% | 187.77% |
| 2018 | -645.59% | 106.78% |
| 2017 | -312.21% | -91.57% |
| 2016 | -3702.09% | 1.35% |
The current ROE of ProMIS Neurosciences, Inc. (PMN) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
902.09%
5-year avg
705.74%
10-year avg
-243.16%
ProMIS Neurosciences, Inc.’s ROE is greater than MapLight Therapeutics, Inc. (-69.06%), greater than Ernexa Therapeutics Inc. (-263.68%), greater than OSR Holdings, Inc. (-15.90%), greater than Lipocine Inc. (-66.69%), less than Adaptimmune Therapeutics plc (472.78%), greater than Edesa Biotech, Inc. (-82.34%), greater than Adlai Nortye Ltd. (-414.01%), greater than GeoVax Labs, Inc. (-709.51%), greater than Tharimmune, Inc. (-36.93%), greater than BioRestorative Therapies, Inc. (-423.84%),
| Company | ROE | Market cap |
|---|---|---|
| -69.06% | $22.75M | |
| -263.68% | $1.95M | |
| -15.90% | $9.63M | |
| -66.69% | $13.52M | |
| 472.78% | $75.16M | |
| -82.34% | $65.36M | |
| -414.01% | $536.11M | |
| -709.51% | $1.28M | |
| -36.93% | $139.94M | |
| -423.84% | $3.68M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ProMIS Neurosciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like ProMIS Neurosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is ProMIS Neurosciences, Inc.'s ROE?
How is the ROE calculated for ProMIS Neurosciences, Inc. (PMN)?
What is the highest ROE for ProMIS Neurosciences, Inc. (PMN)?
What is the 3-year average ROE for ProMIS Neurosciences, Inc. (PMN)?
What is the 5-year average ROE for ProMIS Neurosciences, Inc. (PMN)?
How does the current ROE for ProMIS Neurosciences, Inc. (PMN) compare to its historical average?